4
Changes in Ownership
Rapport Therapeutics, Inc. Filed Acc 0001193125-26-266086
Options or other derivatives
- Director acquired 15,200 shares (grant or award)
From the SEC's structured data for this filing
Rapport Therapeutics, Inc. Filed Acc 0001193125-26-266086
Options or other derivatives
From the SEC's structured data for this filing
Connection lost
Reconnecting…
Cite Filings isn't responding
Reconnecting…